Why You Should Use SDOH Data to Target GLP-1 Users More Effectively
The surge in GLP-1 demand—driven by drugs like Ozempic, Wegovy,
and Mounjaro—is not just a medical trend, it’s a consumer
movement.
Why whole-person insights belong in every health platform
Learn how tools and marketplaces like Datavant are leveling up access to insights.
